For the first time, researchers have used machine learning—a type of artificial intelligence (AI)—to identify the most ...

A new long-term prediction tool estimates the risk of dying from prostate cancer, offering a more accurate way to interpret ...

After radiation therapy, certain cancer patients face a lingering question: Is a troubling lesion a return of the cancer, or ...

Noetik CEO and co-founder Ron Alfa, M.D., Ph.D., said the licensing of human foundation models is “a new paradigm in biotech.” With the GSK deal validating the paradigm, in Alfa’s view, Noetik ...

In this cohort study, a novel prognostic model was developed to estimate prostate cancer-specific mortality (PCSM) while ...